Innoviva Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
16
Price Target
$16.00
Consensus
Neutral
Upside
25.00%
Analysts
0
Stock Rating
16
Upside
25.00%
Analysts
0
Price Target
$16.00

Innoviva Stock Forecast and Price Target

The average target price for Innoviva's stock set by renowned analysts in recent months is $16.00, representing a potential upside of approximately 25% from its last closing price if met by 2024. This estimation is based on a high estimate of $28.00 and a low estimate of $12.00. If you are interested in INVA stock, it is important to also consider its competitors.

$16.00

25.00% Upside

Hold
Hold

Innoviva Fair Value Forecast for 2023 - 2025 - 2030

Innoviva's Price has seen impressive growth In the last two years, rising from $11.11 to $22.30 – a growth of 100.70%. 0 analysts predict Innoviva's Fair Value will decrease by 25.28% in the next year, reaching $16.66. By 2030, professionals predict that Innoviva's Fair Value will decrease by 20.98%, to $17.62.

2022 Fair Value Forecast
$16.66
2023 Fair Value Forecast
$15.36
2024 Fair Value Forecast
$16.58
2025 Fair Value Forecast
$18.51
2026 Fair Value Forecast
$17.94
2027 Fair Value Forecast
$17.06
2028 Fair Value Forecast
$16.94
2029 Fair Value Forecast
$17.45
2030 Fair Value Forecast
$17.62

Innoviva Revenue Forecast for 2023 - 2025 - 2030

Innoviva's Revenue has seen impressive growth In the last two years, rising from $261.02M to $391.87M – a growth of 50.13%. 0 analysts predict Innoviva's Revenue will decrease by 16.87% in the next year, reaching $325.75M. By 2030, professionals predict that Innoviva's Revenue will decrease by 14.75%, to $334.06M.

2022 Rev Forecast
$0.33B
2023 Rev Forecast
$0.31B
2024 Rev Forecast
$0.32B
2025 Rev Forecast
$0.34B
2026 Rev Forecast
$0.34B
2027 Rev Forecast
$0.33B
2028 Rev Forecast
$0.33B
2029 Rev Forecast
$0.33B
2030 Rev Forecast
$0.33B

Innoviva Dividend per Share Forecast for 2023 - 2025 - 2030

Innoviva Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Innoviva's Free Cash Flow has seen an increase, rising from $257.45M to $363.80M. This represents a growth of 41.31%. The next year, 0 experts forecast that Innoviva's Free Cash Flow will decrease by 15.22%, reaching $308.44M. In 2030, professionals predict that Innoviva's Free Cash Flow will decrease by 13.46%, reaching $314.85M.

2022 FCF Forecast
$0.31B
2023 FCF Forecast
$0.29B
2024 FCF Forecast
$0.30B
2025 FCF Forecast
$0.32B
2026 FCF Forecast
$0.32B
2027 FCF Forecast
$0.31B
2028 FCF Forecast
$0.31B
2029 FCF Forecast
$0.31B
2030 FCF Forecast
$0.31B

Innoviva Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Innoviva's Net Income has grown, moving from $157.29M to $265.85M – an increase of 69.02%. In the following year, the 0 analysts surveyed believe that Innoviva's Net Income will decrease by 20.36%, reaching $211.71M. According to professionals, by 2030, Innoviva's Net Income will have decreased by 17.41%, falling down to $219.56M.

2022 NI Forecast
$0.21B
2023 NI Forecast
$0.20B
2024 NI Forecast
$0.21B
2025 NI Forecast
$0.23B
2026 NI Forecast
$0.22B
2027 NI Forecast
$0.21B
2028 NI Forecast
$0.21B
2029 NI Forecast
$0.22B
2030 NI Forecast
$0.22B

Innoviva EBITDA Forecast for 2023 - 2025 - 2030

Innoviva's EBITDA has seen growth In the last two years, going from $249.51M to $378.41M – a gain of 51.66% According to the 0 analysts polled, in the next year, Innoviva's EBITDA will fall by 17.36%, reaching $312.71M. By 2030, professionals believe that Innoviva's EBITDA will have decreased by 15.14%, falling to $321.13M.

2022 EBITDA Forecast
$0.31B
2023 EBITDA Forecast
$0.30B
2024 EBITDA Forecast
$0.31B
2025 EBITDA Forecast
$0.33B
2026 EBITDA Forecast
$0.33B
2027 EBITDA Forecast
$0.32B
2028 EBITDA Forecast
$0.31B
2029 EBITDA Forecast
$0.32B
2030 EBITDA Forecast
$0.32B

Innoviva EBIT Forecast for 2023 - 2025 - 2030

In the last two years, EBIT for Innoviva has grown by 51.69%, going from $249.46M to $378.40M. For the next year, 0 analysts project Innoviva's EBIT to drop by 17.37%, reaching $312.68M. By 2030, professionals believe that Innoviva's EBIT will decrease by 15.14%, reaching $321.10M – a concerning trend for the company.

2022 EBIT Forecast
$0.31B
2023 EBIT Forecast
$0.30B
2024 EBIT Forecast
$0.31B
2025 EBIT Forecast
$0.33B
2026 EBIT Forecast
$0.33B
2027 EBIT Forecast
$0.32B
2028 EBIT Forecast
$0.31B
2029 EBIT Forecast
$0.32B
2030 EBIT Forecast
$0.32B

Innoviva EPS Price Prediction Forecast for 2023 - 2025 - 2030

Innoviva's EPS has seen impressive growth In the last two years, rising from $1.43 to $2.87 – a growth of 100.70%. 0 analysts predict Innoviva's EPS will decrease by 25.28% in the next year, reaching $2.14. By 2030, professionals predict that Innoviva's EPS will decrease by 20.98%, to $2.27.

2022 EPS Forecast
$2.14
2023 EPS Forecast
$1.98
2024 EPS Forecast
$2.13
2025 EPS Forecast
$2.38
2026 EPS Forecast
$2.31
2027 EPS Forecast
$2.20
2028 EPS Forecast
$2.18
2029 EPS Forecast
$2.25
2030 EPS Forecast
$2.27